Image for Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders

Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders : Proceedings of a Workshop

See all formats and editions

Psychiatric illnesses - such as major depressive disorder, anxiety disorder, substance use disorder, and posttraumatic stress disorder (PTSD) - are widely prevalent and represent a substantial health burden worldwide.

Yet, conventional medications for mental illnesses often fail to provide relief to patients' disruptive and disabling symptoms.

Existing and emerging evidence that psychedelics (e.g., LSD and psilocybin) and entactogens (e.g., MDMA) may be useful as tools to alleviate mental illness has sparked a renaissance of interest by investigators, clinicians, drug developers, and patient advocates in recent years.

While promising data on therapeutic efficacy has energized research and development, resolving the mechanisms of action will be important for optimizing the efficacy and safety of these medicines.

Further, evaluating the effect of psychedelics and entactogens on mood and behavior comes with unique challenges still in need of resolution.

These include unresolved questions relating to blinding, placebo and nocebo effects, and the impact of psychosocial contexts. In response to this renewed interest, the National Academies of Sciences, Engineering, and Medicine's Forum on Neuroscience and Nervous System Disorders convened a workshop on March 29-30, 2022.

The workshop brought together a diverse group of stakeholders to explore the use of psychedelics and entactogens as treatments for psychiatric disorders.

This Proceedings of a Workshop summarizes the presentations and discussions of the workshop. Table of ContentsFront Matter1 Introduction and Background2 History and Current Status of Psychedelics and Entactogens forthe Treatment of Psychiatric Disorders3 Mechanisms of Action and Key Research Gaps for Psychedelics andEntactogens4 Advancing Clinical Development: Challenges and Opportunities5 Anticipating Implementation to Guide Clinical Research andDevelopment6 Reflecting on the Road AheadAppendix A: ReferencesAppendix B: Workshop Agenda

Read More
Special order line: only available to educational & business accounts. Sign In
£13.99
Product Details
National Academies Press
0309691370 / 9780309691376
Paperback / softback
615
28/12/2022
United States
English
96 pages
152 x 229 mm